Pages that link to "Q71607874"

The following pages link to Residence half-life of IgG administered topically to the mouse vagina (Q71607874):

Displaying 23 items.

• Immunocontraceptives: new approaches to fertility control (Q26866008) (← links)
• Nanoparticle transport from mouse vagina to adjacent lymph nodes (Q27329123) (← links)
• Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen. (Q30468622) (← links)
• Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus (Q30478934) (← links)
• Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops (Q30942705) (← links)
• Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission (Q33245411) (← links)
• Which topical microbicides for blocking HIV-1 transmission will work in the real world? (Q33253661) (← links)
• Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases (Q33542433) (← links)
• Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice (Q34002354) (← links)
• In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery (Q35563449) (← links)
• Clinical trial considerations on male contraception and collection of pregnancy information from female partners (Q36185639) (← links)
• Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update (Q37124400) (← links)
• Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake (Q37158237) (← links)
• Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs (Q38260862) (← links)
• Polymeric controlled delivery for immunization (Q41591509) (← links)
• Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. (Q45729198) (← links)
• Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes (Q47961048) (← links)
• Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice (Q51166879) (← links)
• Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix (Q51840254) (← links)
• Topical antibody delivery systems produce sustained levels in mucosal tissue and blood (Q74259482) (← links)
• A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes (Q77683899) (← links)
• Comparison of an anti-HSV-2 monoclonal IgG and its IgA switch variant for topical immunoprotection of the mouse vagina (Q77714660) (← links)
• Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV (Q93032857) (← links)